Although several studies suggest that it is the lack of CD24 expression that characterizes breast cancer stem cells [14, 15], it is known that cell-surface markers are not conserved among different tumors, due to differences in the driver mutations [4]. The gene discussed is CD24; the disease is breast carcinoma.